[HTML][HTML] Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and …

J Shi, DX Ma, SH Gao, F Long, X Wang, XY Pu… - Frontiers in …, 2023 - frontiersin.org
Introduction Obesity and diabetes are common chronic metabolic disorders which can cause
an imbalance of the intestinal flora and gut-liver metabolism. Several studies have shown …

[HTML][HTML] E. coli Nissle 1917 ameliorates mitochondrial injury of granulosa cells in polycystic ovary syndrome through promoting gut immune factor IL-22 via gut …

M Luo, Y Chen, X Pan, H Chen, L Fan… - Frontiers in …, 2023 - frontiersin.org
Objective Gut microbiota and its metabolites have regulatory effects on PCOS related
ovarian dysfunction and insulin resistance. Escherichia coli Nissle 1917 (EcN) is a …

[PDF][PDF] Probiotic intervention in the treatment of diabetes mellitus: a review

N Sreepathi, MK Jayanthi, SJ Chandra… - J. Pure Appl …, 2022 - researchgate.net
Diabetes is a noncommunicable lifestyle condition that impacts millions of individuals
worldwide. Diabetes is a physiological illness that affects several different organs in the …

[HTML][HTML] Comparison of Glucose Metabolizing Properties of Enterobacterial Probiotic Strains In Vitro

J Balanche, E Lahaye, L Bremard, B Thomas… - Nutrients, 2024 - mdpi.com
Before the absorption in the intestine, glucose encounters gut bacteria, which may serve as
a barrier against hyperglycemia by metabolizing glucose. In the present study, we compared …

Elucidating the biodegradation pathway for the pharmaceutical metformin in wastewater: Implications in human and wastewater microbiomes

LJ Tassoulas - 2023 - search.proquest.com
Abstract Metformin (1, 1-dimethylbiguanide) is a wonder drug and a pervasive pollutant
which is taken by type-II diabetes patients and more recently for improving obesity and …